VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

COSTEM 2022 | Identifying post-transplant secondary pulmonary infections

Michael Boeckh, MD, PhD, Fred Hutchinson Cancer Research Center, Washington, WA, discusses various secondary respiratory tract infections patients may receive after stem cell transplantation, especially in immunocompromised individuals. Infections such as respiratory syncytial virus (RSV), human metapneumovirus and parainfluenza viruses may negatively affect outcomes and Dr Boeckh highlights research in the epidemiology and management of these diseases, as well as how the immune system controls infection. This interview took place at the 7th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter